Calcium Channel Blockers + Pimecrolimus Interaction
Moderateinteraction on record
Description
CYP3A inhibitors; concomitant use in patients with widespread and/or erythrodermic disease should be done with caution due to potential for increased pimecrolimus levels.
Mechanism
CYP3A inhibition
Source: NLP:pimecrolimus